69 Best Drug Delivery Startups to Watch in 2025

The Definitive Seedtable Ranking of Drug Delivery Startups

We track 71,000+ companies and rank them dynamically using our Seedtable Score – a score that uses quantitative and qualitative data points to signal the momentum behind a company. We then monitor the list manually leveraging our expertise as founders and investors.

There are 178 start-ups with an aggregate funding of $3.4b. The average funding per company in this subset is $48.8m.

Last update to the database: Feb 18, 2025. See changelog.

See all results for this search

Track over 71,000 companies

Discover
Fast-growing Global startups

Seedtable uses technology and people to track over 71,000 companies to help you find the right ones to partner with.

Pricing + Sign up

1

Funding Rounds

$24.1m

Money raised

Neos Therapeutics is a pharmaceutical company developing ADHD medications founded in 2008.

16

Funding Rounds

$328.8m

Money raised

ViaCyte is a biotechnology company using stem cells to create pancreatic beta cell precursors for treating diabetes.

9

Funding Rounds

$82.6m

Money raised

Biotherapeautics company founded in 2014 and based in Paris that uses proprietary methods in synthetic biology, protein and genome engineering to produce Eligobiotics, products which intervene with the microbiome as diagnostics, antimicrobials and modulators of host-microbiome interactions.

Location:

Key people:

6

Funding Rounds

$4.6m

Money raised

Nanomedicine company developing vaccines and therapies with cell-specific targeting.

6

Funding Rounds

$86.6m

Money raised

Prokarium is a biopharmaceutical company focused on developing vaccination and cancer immunotherapy solutions based on synthetic biology.

Location:

Key people:

3

Funding Rounds

$143.4m

Money raised

An exosome therapeutics company founded in 2016 and based in Oxford, UK, that uses exosomes to deliver small and large molecule therapeutics. The company has a proprietary technology to modify exosomes to target specific organs such as the brain and central nervous system.

Key people:

4

Funding Rounds

$7.1m

Money raised

Oisin develops anti-aging treatments that target and remove senescent cells, a type of damaged cell that is unable to divide, accumulates during aging and contribute to age-related diseases.

Location:

Key people:

2

Funding Rounds

$56.6m

Money raised

CeQur is a wearable mealtime insulin device maker founded in 2008 by Joël Besse.

4

Funding Rounds

$46.7m

Money raised

Juventas Therapeutics is a biotechnology company founded in 2007 that is headquartered in Cleveland, Ohio developing a pipeline of regenerative therapies to treat life-threatening diseases.

Location:

Key people:

2

Funding Rounds

$645.0k

Money raised

CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia to deliver bioactive molecules to treat diseases associated with the human gut microbiome.

2

Funding Rounds

$22.2m

Money raised

TFF Pharmaceuticals is a dry-powder Inhalation for Respiratory Therapies founded in 2018.

1

Funding Rounds

$5.9m

Money raised

Encellin is a biotechnology company developing diabetes therapeutics using insulin responsive cells.

Key people:

1

Funding Rounds

$3.9m

Money raised

Tempo Therapeutics is an interventional biomaterials for regenerative medicine company founded by Westbrook Weaver.

Key people:

1

Funding Rounds

$400.0k

Money raised

Xycrobe Therapeutics is a biotechnology company developing microbiome-Based, biotherapeutic delivery systems.

3

Funding Rounds

$121.0m

Money raised

Anjarium is an early-stage biotechnology company developing next-generation, non-viral gene therapy therapeutics.

Location:

Key people:

3

Funding Rounds

$50.6m

Money raised

Cambridge, MA-based company developing targeted mRNA therapeutics for cancer and other diseases.

Key people:

1

Funding Rounds

$2.0m

Money raised

A biotechnology company founded in 2006 and based in Baltimore, MD, that develops polymers to deliver DNA and RNA therapeutics.

5

Funding Rounds

$93.6m

Money raised

A clinical-stage pharmaceutical company in Colorado that focuses on treatments for refractory epilepsy.

1

Funding Rounds

$21.6m

Money raised

A pharmaceutical company developing oral therapies for chronic diseases.

1

Funding Rounds

Biotherapeutics company focused on medicines for chronic inflammation, metabolic disease and autoimmune disease

13

Funding Rounds

$123.5m

Money raised

CellCentric is a clinical stage biotechnology company that focuses on developing first of its kind.

3

Funding Rounds

$191.8m

Money raised

Diabeloop is a Grenoble-based company founded in 2015.

1

Funding Rounds

$22.8m

Money raised

Vaxxas is commercializing a novel vaccination technology that dramatically enhances the performance of existing and next-generation vaccines.

2

Funding Rounds

$72.9m

Money raised

Orexo is a pharmaceutical company developing and commercializing drugs founded in 1995 by Anders Pettersson, Christer Nyström and Thomas Lundqvist.

1

Funding Rounds

Entos Pharmaceuticals develops nucleic acid-based therapies using its proprietary Fusogenix drug delivery system.

2

Funding Rounds

$8.5m

Money raised

PepVax Inc. is a Washington DC-based biotechnology company.

3

Funding Rounds

$34.5m

Money raised

GenEdit develops technology for gene editing.

Key people:

1

Funding Rounds

$3.4m

Money raised

Carmine Therapeutics is a Cambridge, Massachusetts-based company developing novel types of gene therapies utilizing extracellular vesicles produced in laboratory.

Key people:

1

Funding Rounds

$594.1k

Money raised

RepliCel Life Sciences is a biotechnology company developing regenerative medicines primarily using autologous cell therapy.

2

Funding Rounds

$5.6m

Money raised

PDX Pharmaceuticals, Inc. is a company in the pharmaceuticals industry founded by Wassana Yantasee in 2010.

Key people:

2

Funding Rounds

$20.0m

Money raised

Bionaut Labs develops precision medicine treatments for CNS disorders.

Location:

Key people:

4

Funding Rounds

$194.9m

Money raised

Bigfoot Biomedical is an insulin delivery pump founded in 2014.

1

Funding Rounds

$40.0m

Money raised

Corium International is a transdermal Generics, Consumer Products founded in 1999.

2

Funding Rounds

$22.3m

Money raised

leon-nanodrugs is a Bayern, Germany-based company that specializes in researching and developing nanotechnology-based drugs.

1

Funding Rounds

$10.0m

Money raised

Sixfold Bioscience is a biotechnology firm focused on advancing RNA therapies founded in 2017 by Anna Perdrix Rosell, Zuzanna Brzosko and George Foot.

1

Funding Rounds

$22.5m

Money raised

Collegium Pharmaceutical is a company developing products for pain management founded in 2002.

3

Funding Rounds

$16.4m

Money raised

AmacaThera is a hydrogel-based drug delivery founded in 2016 by Molly Shoichet.

Location:

Key people:

1

Funding Rounds

$6.9m

Money raised

Pantec Biosolutions AG develops drug delivery solutions for a variety of medical applications.

Location:

Key people:

4

Funding Rounds

SiSaf is the first company to create a Bio-Courier platform technology.

5

Funding Rounds

$12.2m

Money raised

NanoMedical Systems is a personalized Molecular Drug-delivery System Implant founded in 2007 by Mauro Ferrari, David D. Saathoff and Randy Goodall.

3

Funding Rounds

$92.0m

Money raised

Micro-organosphere technologies to guide precision therapy for cancer patients

1

Funding Rounds

$11.5m

Money raised

Gilero is a Morrisville, North Carolina-based company offering device design, development, and contract manufacturing services in the medical and pharmaceutical industries.

Key people:

2

Funding Rounds

$330.0k

Money raised

Sensulin is an insulin manufacturing company founded by Ananth Annapragada, Mike Moradi, Chris Rhodes and Dan Bradbury.

3

Funding Rounds

$143.0m

Money raised

Lyndra Therapeutics is a drug Delivery founded in 2015.

1

Funding Rounds

$2.9m

Money raised

Vesigen Therapeutics is a company in Cambridge, Massachusetts.

1

Funding Rounds

$2.4m

Money raised

VALANX Biotech is a company enabling antibody drug conjugates

Location:

Key people:

2

Funding Rounds

$150.0m

Money raised

Ceptur Therapeutics is Revolutionizing RNA Therapeutics with U1 Adaptor Technology to Develop Medicines for Unaddressed Diseases

Industries:

Location:

2

Funding Rounds

$17.2m

Money raised

Pharmaco-Kinesis Corporation is a high-end medical device technology company.

3

Funding Rounds

$19.9m

Money raised

Pharnext is a very well advanced clinical-stage biopharmaceutical company

2

Funding Rounds

$53.0m

Money raised

Flexion Therapeutics is an american biotechnology company founded in 2007.

2

Funding Rounds

$30.1m

Money raised

A company developing precision drug delivery systems and products

2

Funding Rounds

$22.5m

Money raised

Periphagen is a biopharmaceutical company founded in 2012 by Darren Wolfe

Location:

Key people:

1

Funding Rounds

$3.1m

Money raised

Developer of innovative peptides designed to offer targeted therapies for severe diseases, with an initial focus on oncology. The company's peptides are active compounds that penetrate cells and block relevant intracellular protein interactions that offer intracellular delivery of targeted therapies.

Location:

Key people:

3

Funding Rounds

$159.3m

Money raised

A medical device company developing surgical renal denervation for the treatment of hypertension

2

Funding Rounds

$321.0m

Money raised

Orna Therapeutics is a biotechnology company dedicated to designing and delivering a new class of fully engineered circular RNA (oRNA) therapeutics.

2

Funding Rounds

$72.1m

Money raised

InCarda Therapeutics is a company developing therapies for cardiovascular diseases founded in 2009 by Carlos A. Schuler.

1

Funding Rounds

$1.6m

Money raised

Cello Therapeutics, Inc. (Cello) was founded in April 2016 and specializes in the development of nanoparticles for cancer treatment.

1

Funding Rounds

$3.0m

Money raised

Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy. The company's platform TERP overcomes the poor drug release and liver accumulation of lipid nanoparticles and efficiently delivers drugs, antibodies and RNA to hard-to-reach tumors, including the brain.

1

Funding Rounds

$65.0m

Money raised

CF PharmTech is a specialty Respiratory Pharmaceuticals founded in 2007.

2

Funding Rounds

$3.0m

Money raised

3Bar Biologics is a microbe delivery and manufacturing company that partners with microbe discovery and commercialization companies.

2

Funding Rounds

$10.2m

Money raised

BioLight Life Sciences Ltd. is devoted to the development of products and diagnostic solutions for ophthalmic conditions.

Location:

Key people:

2

Funding Rounds

$1.5m

Money raised

Microdermics is a skincare company founded in 2014 by Grant Campany, Boris Stoeber, Sahan Ranamukhaarachchi and Iman Mansoor.

3

Funding Rounds

$12.0m

Money raised

EnClear Therapies is a biotechnology company developing device-based therapies for the treatment of neurodegenerative disease

Key people:

7

Funding Rounds

$27.6m

Money raised

410 Medical Inc is an emergency Infusion Device founded in 2013.

2

Funding Rounds

$167.0m

Money raised

Ring Therapeutics is a multi-product platform company.

Key people:

3

Funding Rounds

$5.5m

Money raised

2C Tech Corporation, Inc. is a nanoparticles for Ophthalmology founded by Naresh Mandava.

4

Funding Rounds

$57.1m

Money raised

Adocia is a molecular Delivery System for Therapeutic Proteins founded in 2005.

2

Funding Rounds

$3.1m

Money raised

Chameleon Biosciences Inc. is a gene therapy company.

1

Funding Rounds

$781.1k

Money raised

Lauren Sciences is a New York City-based biotechnology company providing a targeted drug delivery platform and nanomedicine-based solutions.

Location:

Key people:

Sign up to access our full database

Enter your email and get access to 71,000 + technology companies you can partner with.

Join 29000+ founders, operators, and investors.